PEBP1 and schizophrenia: A study with a rare CNVs analysis by WGS suggested that a de novo deletion that affects TAOK3 (and PEBP1) may contribute to schizophrenia (Malhotra et al., 2011) and TAOK3 (but not PEBP1) was further confirmed in a GWAS analysis (Gilman et al., 2012), suggesting LOF of monogenic TAOK3 may contribute to NDDs, at least in schizophrenia.